Cancer risk reduction

“Work on further reducing production costs will continue post-launch...

Swiss player ready for reduced cost resveratrol launch

By Shane STARLING

10-year-old Swiss biotech firm Evolva has completed the resveratrol manufacturing cost-reduction programme it embarked on for the antioxidant nearly two years ago when it bought defunct Fluxome’s business for €550,000.

“Our analysis suggests that nutrient databases require regular updating, especially for nutrients that are added to foods by manufacturers...

More vitamin D in UK foods than previously: Study

By Shane STARLING

The UK should update vitamin D food and supplement content estimations that have the knock-on effect of distorting population intake levels of the sunshine vitamin by about 3%, a study has concluded.

FDA exemption speeds release of Plandai’s catechin supplement

FDA exemption speeds release of Plandai’s catechin supplement

By Maggie Hennessy

Plandai Biotechnology Inc. will not be required to apply to the US Food and Drug Administration for New Dietary Ingredient status in order to market and sell its Phytofare Catechin Complex as a dietary supplement, enabling the firm to start marketing...

Policing social media made easier with new tool from Ingredient Identity

Policing social media made easier with new tool from Ingredient Identity

By Hank Schultz

Consulting firm Ingredient Identity is offering a way to help companies manage their social media platforms to avoid crossing regulatory boundaries.  The new subscription service can help flag posts that make disease claims that could bring unwanted attention...

DSM: Additional research will underpin vitamin E's decisive benefits

DSM: Additional research will underpin vitamin E's decisive benefits

By Hank Schultz

Magic bullet syndrome is something that has plagued the dietary supplement ingredient business over the years. While this is often negative for consumers, who put their faith into an overhyped (while still possibly effective) ingredient, it’s not so good...

Vitamin D levels linked to cancer survival rates

By Annie Harrison-Dunn

Breast and colorectalcancer patients with higher levels of vitamin D at the time of diagnosis may have better chances of survival and remain in remission longer those who are deficient, according to a scientific review. 

Not all folate forms are the same argues Dr Robert Verkerk

Folic acid: The double-edge sword of the golden micronutrient

Folic acid is backed to deliver important health benefits in the scientific literature and by regulators – but is over-consumption a real problem? asks Robert Verkerk, PhD, the founder, executive and scientific director of the Alliance for Natural Health...

Metabolites of EPA, DHA ripe area for innovation, expert says

Metabolites of EPA, DHA ripe area for innovation, expert says

By Hank Schultz

Innovation in omega-3s has come in many forms.  New delivery modes, new raw material sources, and new chemical forms.  But through it all, the story has always been about  EPA and DHA as whole molecules. That might be about to change.

Time has come to consider DRIs for bioactives, CRN official says

Time has come to consider DRIs for bioactives, CRN official says

By Hank Schultz

Evidence for the nutrtional benefits of bioactives is steadily accumulating, and the time has come engage regulators in a process of determining dietary reference intakes (DRIs) for the best-researched substances, said Jim Griffiths, vice president of...

Cancer researcher wins ABC's Farnsworth award

Cancer researcher wins ABC's Farnsworth award

By Hank Schultz

Influential figures in the herbal sphere aren’t always involved in what most would term “natural” products.  So it is with Gordon M Cragg, PhD, the latest recepient of a prominent award from the American Botanical Council.

FTC files brief justifying restriction of POM's First Amendment rights

FTC files brief justifying restriction of POM's First Amendment rights

By Hank Schultz

The Federal Trade Commission has filed a long awaited brief in POM Wonderful’s appeal of a false advertising case against the company.  As expected, FTC contends that POM’s ads were deceptive, and the company lacked sufficient clinical data to back up...

Global tea polyphenols market set to hit $368 million by 2020

Special edition: Polyphenols

Global tea polyphenols market set to hit $368 million by 2020

By Hank Schultz

Tea polyphenols are poised to enjoy strong growth over the next decade, with a new market report calling for the global market in the ingredients to hit $368 million by 2020.  That makes sense to observers, who say the popularity of tea, green tea in...

CRN on silencing the critics with a dose of research

Guest Article

CRN on silencing the critics with a dose of research

By Steve Mister, President & CEO, Council for Responsible Nutrition

These are confusing times to be a dietary supplement consumer – one day, a particular nutrient is touted as a magic bullet, and the next it’s a waste of money. In this constant news cycle we live in, consumers are left even more puzzled about what’s really...